Lifecore Biomedical, Inc. Common Stock

LFCRNASDAQUSD
4.25 USD
0.13 (3.16%)🔴AT CLOSE (AS OF 07:31 PM EDT)
🔴Market: CLOSED

Shares of Lifecore Biomedical, Inc. Common Stock (LFCR) are trading at $4.25. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place LFCR at a fair price relative to peers.

Technical & fundamental data as of Sep 14, 2026.

Open?$4.12
High?$4.28
Low?$4.02
Prev. Close?$4.12
Volume?110.7K
Avg. Volume?138.9K
VWAP?$4.21
Rel. Volume?0.80x
Bid / Ask
Bid?$3.60 × 100
Ask?$4.87 × 100
Spread?$1.27
Midpoint?$4.24
Valuation & Ratios
Market Cap?156.0M
Shares Out?37.9M
Float?27.4M
Float %?73.2%
P/E Ratio?N/A
P/B Ratio?116.73
EPS?-$1.36
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
Employees
382
Market Cap
156.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1996-02-15
Address
3515 LYMAN BOULEVARD
CHASKA, MN 55318
Phone: (952) 368-4300
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
2
Momentum?
50
Short Sent.?
28
Piotroski F-Score?5/9Mixed
Altman Z-Score?-0.18Distress
Confidence?55%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?8.83%Elevated
Short Interest?2.4M
Days to Cover?23.2
Free Float27.4M
Avg Daily Volume104.5K
Settlement Date2026-08-31
Financial Health
Current Ratio?2.84Strong
Quick Ratio?1.77Adequate
Cash Ratio?0.27Low
Debt/Equity?4.34High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
3
116.73HIGH
P/S?
Peers
100
S&P
84
1.19CHEAP
P/FCF?
N/A
EV/EBITDA?
S&P
97
-21.9CHEAP
EV/Sales?
Peers
100
S&P
89
1.17CHEAP
Returns & Efficiency
ROE?
S&P
3
-3,840.6%WEAK
ROA?
S&P
3
-21.4%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$153.5M
Fundamentals ratios updated end of day